← Decoding · MEPS Explorer

MEPS Individual Reports

Deep-dive analysis pages built from the 2023 MEPS Full-Year Consolidated file (HC-251). Variables marked with a blue REPORT badge in the explorer link directly to these pages.

Expenditure Analysis 8 REPORT-badged variables → expenditure breakdown
TOTEXP23 +7
Healthcare Expenditure by Payer REPORT
Total expenditure and breakdown by payer: Self/OOP, Private Insurance, Medicare, Medicaid, VA/CHAMPVA, TRICARE, Other. Includes coverage rate, distribution curves, and split by age group / income level.
→
Prescribed Medicines HC-248A · drug-level payer & channel analysis
HC-248A
PCSK9 Inhibitors — Payer Mix, Channel & Cost REPORT
Payer split (proportional attribution), pharmacy channel, product mix, and cost-per-day analysis for PCSK9 inhibitors. MEPS 2023 captures evolocumab (Repatha) only. 154 fills · 29 patients.
→ HC-248A
HRT Method & Product Frequency — Female 45–69 REPORT
Menopause HRT prevalence by delivery method and therapy regimen (systemic vs. local), 2020–2023 · 3.9–5.6% of eligible women. Includes product frequency ranking: top 10 product types per year with year-over-year rank change.
→ HC-248A
Drug Payer & Channel Explorer REPORT
Interactive — search and select any of 532 drugs in the 2023 file to see combined payer split (proportional attribution) and pharmacy channel mix. Multi-drug selections are deduplicated by patient.
→
In Progress planned deep-dive pages
INSCOV23
Insurance Coverage Status Coming soon
Coverage breakdown: private, public, uninsured. Age and income stratification.
TOTSLF23
Out-of-Pocket Spending Coming soon
Self-pay burden distribution across demographics and insurance types.
DLAYCA42
Delayed / Foregone Care Coming soon
Who delayed or skipped care due to cost, and how that varies by income and coverage status.